Skip to main content
. 2010 Sep;161(1):103–112. doi: 10.1111/j.1476-5381.2010.00870.x

Table 2.

[3H]SR141716A Bmax values and % down-regulation in membranes from various brain regions in vehicle- and THC-treated adolescent and adult rats of both sexes

Female adolescents Female adults Male adolescents Male adults
Brain region Veh THC % DR Veh THC % DR Veh THC % DR Veh THC % DR
Prefrontal Cortex 4.5 3.4 23% 2.3 1.7 23% 4.8 3.8 20% 2.4 1.8 26%
(0.15) (0.18) (5.8) (0.13) (0.09) (6.5) (0.11) (0.14) (3.2) (0.09) (0.17) (5.0)
Striatum 3.4 2.8 17% 1.8 1.5 16% 4.1 3.4 18% 2.0 1.6 20%
(0.12) (0.06) (3.8) (0.05) (0.03) (3.8) (0.08) (0.24) (4.6) (0.04) (0.07) (4.5)
Hypothalamus 5.5 2.9 47% 3.8 1.9 50% 5.4 3.0 44% 2.7 1.5 45%
(0.12) (0.06) (1.4) (0.10) (0.08) (2.2) (0.15) (0.06) (1.5) (0.09) (0.06) (3.8)
Ventral midbrain 4.1 2.9 30% 2.9 2.1 29% 5.2 3.7 28% 3.7 2.6 29%
(0.08) (0.08) (2.5) (0.04) (0.05) (2.3) (0.19) (0.15) (3.6) (0.14) (0.09) (2.9)

Each value in columns labelled ‘Veh’ and ‘THC’ represents mean Bmax value (SEM), expressed in pmol per mg of membrane protein. % DR = % down-regulation =Bmax value of THC-treated rats expressed as a percent of maximal CB1 receptor binding (Bmax) of vehicle-treated rats of corresponding age and sex. Age × sex × treatment anovas followed by Tukey post hoc tests revealed that Bmax values for adolescents were significantly higher than those for adults, regardless of treatment, with age-treatment interaction terms (and associated probability levels) for each region as follows: [prefrontal cortex F(1,40) = 5.5, P= 0.02], [striatum F(1,40) = 4.5, P= 0.04], [hypothalamus F(1,40) = 9.4, P= 0.004], [ventral midbrain F(1,40) = 6.0, P= 0.02]. In addition, the main effects for treatment were significant, indicating that THC treatment decreased Bmax values in each region. In contrast, percent down-regulation for each region did not differ across age and sex.